Primary |
Panic Disorder |
50.0% |
Aggression |
25.0% |
Reading Disorder |
25.0% |
|
Toxicity To Various Agents |
25.0% |
Overdose |
12.5% |
Respiratory Arrest |
12.5% |
Tachycardia |
12.5% |
Treatment Noncompliance |
12.5% |
Tremor |
12.5% |
Wound |
12.5% |
|
Secondary |
Product Used For Unknown Indication |
29.5% |
Depression |
6.6% |
Gastrooesophageal Reflux Disease |
6.6% |
Heart Rate Increased |
6.6% |
Hypertension |
6.6% |
Chronic Obstructive Pulmonary Disease |
4.9% |
Migraine |
4.9% |
Parkinson's Disease |
4.9% |
Anxiety |
3.3% |
Asthma |
3.3% |
Low Density Lipoprotein Increased |
3.3% |
Prophylaxis |
3.3% |
Urinary Tract Infection |
3.3% |
Wolff-parkinson-white Syndrome |
3.3% |
Atrial Flutter |
1.6% |
Autoimmune Thyroiditis |
1.6% |
Bladder Disorder |
1.6% |
Blood Pressure Abnormal |
1.6% |
Fibromyalgia |
1.6% |
Gastric Disorder |
1.6% |
|
Dyspnoea |
10.0% |
Intentional Overdose |
10.0% |
Unevaluable Event |
10.0% |
Completed Suicide |
5.0% |
Hemianopia |
5.0% |
Liposarcoma |
5.0% |
Muscle Contractions Involuntary |
5.0% |
Oxygen Saturation Decreased |
5.0% |
Poisoning |
5.0% |
Premature Baby |
5.0% |
Rash |
5.0% |
Raynaud's Phenomenon |
5.0% |
Tinnitus |
5.0% |
Ventricular Tachycardia |
5.0% |
Vitamin D Decreased |
5.0% |
Weight Decreased |
5.0% |
Weight Increased |
5.0% |
|
Concomitant |
Product Used For Unknown Indication |
36.9% |
Hypertension |
13.0% |
Rheumatoid Arthritis |
5.6% |
Pain |
4.1% |
Anxiety |
3.9% |
Gastrooesophageal Reflux Disease |
3.8% |
Migraine |
3.8% |
Depression |
3.7% |
Tremor |
3.5% |
Sleep Disorder |
2.8% |
Diabetes Mellitus |
2.5% |
Blood Cholesterol Increased |
2.3% |
Chronic Obstructive Pulmonary Disease |
2.0% |
Crohn's Disease |
2.0% |
Vitamin Supplementation |
2.0% |
Cardiac Disorder |
1.7% |
Hypothyroidism |
1.7% |
Multiple Sclerosis |
1.7% |
Prophylaxis |
1.5% |
Blood Pressure |
1.3% |
|
Vomiting |
12.6% |
Weight Decreased |
11.6% |
Weight Increased |
10.5% |
Urinary Tract Infection |
6.3% |
Suicidal Ideation |
5.3% |
Tremor |
5.3% |
Off Label Use |
4.2% |
Pain |
4.2% |
Pain In Extremity |
4.2% |
Pyrexia |
4.2% |
Death |
3.2% |
Drug Ineffective |
3.2% |
Haematemesis |
3.2% |
Incorrect Dose Administered |
3.2% |
Injection Site Pain |
3.2% |
Nausea |
3.2% |
Pulmonary Embolism |
3.2% |
Rheumatoid Arthritis |
3.2% |
Syncope |
3.2% |
Tachycardia |
3.2% |
|
Interacting |
Anaphylactic Reaction |
75.0% |
Migraine |
25.0% |
|
Potentiating Drug Interaction |
100.0% |
|